Leadership

Ms. Fiona yao has more than 18 years of experience in the clinical research industry. Before joining Kant Hongyi, she has many years of experience in international CRO project management and large pharmaceutical enterprises. She has held senior management positions in internationally renowned companies such as IQVIA, PARAXEL and PPD, led and assisted in a number of large international and regional clinical studies and helped the products to be successfully marketed.

Dr. Wang has worked on designing, implementing, analyzing, and reporting all phases of clinical trials over 20 years across a wide spectrum of biopharmaceuticals and medical devices. He has extensive experience in regulatory submissions, interactions with regulatory authorities, product in-licensing, and commercial development. Dr. Wang’s current research interests include applying innovative statistical methodologies into clinical trial designs. He has been providing extensive consultation to clients on study designs and lectures both internally and externally. Prior to joining WuXi Clinical, he worked for PAREXEL as senior director and head of biostatistics, Asia-Pacific Region. Before that, he had senior roles with global pharmaceutical and medical device companies in the US including St. Jude Medical (now Abbott ) and Allergan. Dr. Wang received his PhD degree in Mathematics and completed his postdoctoral fellowship in Biostatistics and Epidemiology in the US.